Prevnar 13 (pneumococcal 13-valent vaccine) is a member of the bacterial vaccines drug class and is commonly used for Pneumococcal Disease Prophylaxis.
Prevnar 13 vaccine is used to prevent infection caused by pneumococcal bacteria. Prevnar 13 contains 13 different types of pneumococcal bacteria.
Pneumococcal disease is a serious infection caused by a bacteria. Pneumococcal bacteria can infect the sinuses and inner ear. It can also infect the lungs, blood, and brain, and these conditions can be fatal.
Prevnar 13 works by exposing you to a small amount of the bacteria or a protein from the bacteria, which causes the body to develop immunity to the disease. Prevnar 13 will not treat an active infection that has already developed in the body.
Prevnar 13 is for use in children from 6 weeks to 5 years old, and in adults who are 50 and older
For children, Prevnar 13 vaccine is given in a series of shots. The first shot is usually given when the child is 2 months old. The booster shots are then given at 4 months, 6 months, and 12 to 15 months of age. Adults usually receive only one dose of the vaccine.
The first injection should be given no earlier than 6 weeks of age. Allow at least 2 months to pass between injections.
If your child is older than 6 months, he or she can still receive Prevnar 13 on the following schedule:
Age 7-11 months: two Prevnar 13 injections at least 4 weeks apart, followed by a third injection after the child turns 1 year (at least 2 months after the second injection);
Age 12-23 months: two Prevnar 13 injections at least 2 months apart;
Age 24 months to 5 years (before the 6th birthday): one Prevnar 13 injection.